Results 161 to 170 of about 1,493,150 (189)

Immunological effects of sublingual immunotherapy with Japanese cedar pollen extract in patients with combined Japanese cedar and Japanese cypress pollinosis

Clinical Immunology, 2020
Sublingual immunotherapy (SLIT) with Japanese cedar (JCe) pollinosis was expected to be effective for Japanese cypress (JCy) pollinosis. However, only a half of JCy pollinosis patients clinically improved. Therefore, we examined the immunological effect of SLIT for JCy pollinosis.
Hirotaka, Kikuoka, Hideaki, Kouzaki, Koji, Matsumoto, Hiroyuki, Arai, Sayuri, Yamamoto, Ichiro, Tojima, Shino, Shimizu, Hiromi, Miyashita, Yukiko, Ogawa, Toshihiro, Osada, Mitsuhiro, Okano, Atsushi, Yuta, Takeshi, Shimizu   +12 more
openaire   +2 more sources

Japanese cedar/Japanese cypress pollen‐dispersion information and the initial therapy

Clinical & Experimental Allergy Reviews, 2010
SummaryThe original initial therapy against pollinosis was introduced to the clinical setting in Japan in the 1980s, led by the launch of anti‐allergic drugs that were expected to exert prophylactic effects. The purpose of the therapy was to control the typical pollinosis seen in Japan: that occurs due to Japanese cedar/Japanese cypress pollens.
openaire   +1 more source

[Pollen information of airborne Japanese cedar pollen using a simulation method].

Arerugi = [Allergy], 1996
We have developed a simulation method of airborne Cryptomeria japonica pollen distribution on a map displayed visually on a TV screen. Each patient can be available the information where the place he or she lives. The pollen season in 1995, we served the information about airborne pollen distribution on a map and C. japonica flowering areas on a map to
Y, Takahashi, S, Kawashima, S, Aikawa
openaire   +1 more source

[Regional differences in the prevalence of Japanese cedar-pollen allergy].

Arerugi = [Allergy], 2010
According to the 2008 survey conducted by Baba et al., the average prevalence of Japanese cedar-pollen allergy is 26.5% in Japan, although there are great regional differences in the prevalence of this disease. In this study, we investigated the causes of its regional differences.Regional differences in the 2008 prevalence of cedar-pollen allergy in 47
Koji, Murayama, Kotaro, Baba, Kimihiro, Okubo   +2 more
openaire   +1 more source

Long-Term Treatment of Japanese Cedar Pollinosis With Japanese Cedar Pollen SLIT Drops and Persistence of Treatment Effect: A Post-Marketing Clinical Trial

Allergology International, 2021
Yoshitaka Okamoto, Kimihiro Okubo, Yasuyuki Nomura   +2 more
exaly  

Japanese cedar pollen allergy immunotherapy

Reactions Weekly, 2019
openaire   +1 more source

Gibberellin-Regulated Protein Sensitization in Japanese Cedar (Cryptomeria japonica) Pollen Allergic Japanese Cohorts

Allergy: European Journal of Allergy and Clinical Immunology, 2021
Tomoyasu Aizawa, Pascal Poncet, Motohiro Ebisawa   +2 more
exaly  

Japanese Cedar pollen allergy immunotherapy-Torii pharmaceutical

Reactions Weekly, 2021
openaire   +1 more source

Cry j I, a Major Allergen of Japanese Cedar Pollen, Has Pectate Lyase Enzyme Activity

Allergy: European Journal of Allergy and Clinical Immunology, 1995
M Kurimoto, M Usui, A Ono
exaly  

DNA Aptamers Against the Cry j 2 Allergen of Japanese Cedar Pollen for Biosensing Applications

Biosensors and Bioelectronics, 2015
Nasa Savory, Wataru Yoshida, Kazunori Ikebukuro   +2 more
exaly